Endogenous IL-33 has no effect on the progression of fibrosis during experimental steatohepatitis.[2017][Oncotarget][10.18632_oncotarget.18335]

Endogenous IL-33 has no effect on the progression of fibrosis during experimental steatohepatitis.[2017][Oncotarget][10.18632_oncotarget.18335]

ID:139783

大小:12.13 MB

页数:12页

时间:2017-06-26

Endogenous IL-33 has no effect on the progression of fibrosis during experimental steatohepatitis.[2017][Oncotarget][10.18632_oncotarget.18335]_第1页
Endogenous IL-33 has no effect on the progression of fibrosis during experimental steatohepatitis.[2017][Oncotarget][10.18632_oncotarget.18335]_第2页
Endogenous IL-33 has no effect on the progression of fibrosis during experimental steatohepatitis.[2017][Oncotarget][10.18632_oncotarget.18335]_第3页
Endogenous IL-33 has no effect on the progression of fibrosis during experimental steatohepatitis.[2017][Oncotarget][10.18632_oncotarget.18335]_第4页
Endogenous IL-33 has no effect on the progression of fibrosis during experimental steatohepatitis.[2017][Oncotarget][10.18632_oncotarget.18335]_第5页
资源描述:

《Endogenous IL-33 has no effect on the progression of fibrosis during experimental steatohepatitis.[2017][Oncotarget][10.18632_oncotarget.18335]》由会员上传分享,免费在线阅读,更多相关内容在学术论文-天天文库

1、www.impactjournals.com/oncotarget/Oncotarget,AdvancePublications2017EndogenousIL-33hasnoeffectontheprogressionoffibrosisduringexperimentalsteatohepatitisPhilippeVasseur1,2,*,SarahDion3,*,AvelineFilliol3,ValentineGenet3,CatherineLucas-Clerc4,GirardJean-Philippe5,ChristineSilvain2,6

2、,Jean-ClaudeLecron2,7,ClairePiquet-Pellorce3andMichelSamson31Serviced’Hépato-Gastroentérologie,CentreHospitalierNordDeux-Sèvres,Thouars,France2LaboratoireInflammationTissusEpithéliauxetCytokines,UniversitédePoitiers,France3InstitutNationaldelaSantéetdelaRechercheMédicale,Institutd

3、eRechercheSantéEnvironnement&Travail,UniversitédeRennes,Rennes,France4ServicedeBiochimie,CentreHospitalierUniversitaire,Rennes,UniversitédeRennes,Rennes,France5InstitutdePharmacologieetdeBiologieStructurale,CentreNationaldelaRechercheScientifique,UniversitédeToulouse,Toulouse,Fran

4、ce6Serviced’Hépato-Gastroentérologie,CentreHospitalierUniversitairedePoitiers,Poitiers,France7Serviced’ImmunologieetInflammation,CentreHospitalierUniversitairedePoitiers,Poitiers,France*TheseauthorshavecontributedequallytothisworkCorrespondenceto:MichelSamson,email:michel.samson@u

5、niv-rennes1.frKeywords:nonalcoholicsteatohepatitis,NASH,nonalcoholicfattyliverdisease,NAFLD,immunecellsReceived:December20,2016Accepted:May15,2017Published:june01,2017Copyright:Vasseuretal.Thisisanopen-accessarticledistributedunderthetermsoftheCreativeCommonsAttributionLicense(CC-

6、BY),whichpermitsunrestricteduse,distribution,andreproductioninanymedium,providedtheoriginalauthorandsourcearecredited.ABSTRACTInterleukin(IL)-33hasbeenrecentlyreportedtobestronglypro-fibrogenicinvariousmodelsofliverdisease.OuraimwastostudytheroleofendogenousIL-33inadiet-inducedmod

7、elofsteatohepatitis.IL-33deficientmiceandwildtype(WT)littermatesreceivedahigh-fatdiet(HFD),orastandarddietfor12weeks.TheHFD-inducedsteatohepatitiswasassociatedwithanupregulationofIL-33transcriptsandprotein.AninsulintolerancetestrevealedlowersystemicinsulinsensitivityinIL-33-/—HFDm

8、icethaninWT-HFDmice.Nevertheless,

当前文档最多预览五页,下载文档查看全文

此文档下载收益归作者所有

当前文档最多预览五页,下载文档查看全文
温馨提示:
1. 部分包含数学公式或PPT动画的文件,查看预览时可能会显示错乱或异常,文件下载后无此问题,请放心下载。
2. 本文档由用户上传,版权归属用户,天天文库负责整理代发布。如果您对本文档版权有争议请及时联系客服。
3. 下载前请仔细阅读文档内容,确认文档内容符合您的需求后进行下载,若出现内容与标题不符可向本站投诉处理。
4. 下载文档时可能由于网络波动等原因无法下载或下载错误,付费完成后未能成功下载的用户请联系客服处理。